用于SARS-CoV-2分子诊断的STANDARD M10即时检验分析仪与NeuMoDx检测法的比较评估数据集。
Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2.
作者信息
Meletis Georgios, Tychala Areti, Gkeka Ioanna, Protonotariou Efthymia, Skoura Lemonia
机构信息
Department of Microbiology, AHEPA University Hospital, S. Kiriakidi str. 1, 54636, Thessaloniki, Greece.
出版信息
Data Brief. 2022 Dec;45:108690. doi: 10.1016/j.dib.2022.108690. Epub 2022 Oct 21.
The STANDARD M10 is a novel cartridge-based real time RT-PCR point of care platform that provides significant advantages regarding SARS-CoV-2 detection including fast turnaround times and no need for specialized personnel and facilities. This assay was recently evaluated in our hospital as a rapid alternative to the already present NeuMoDx assay that is used in everyday practice. For this purpose, 30 nasopharyngeal samples by patients admitted to our hospital were used, regardless of clinical suspicion of COVID-19. In our evaluation, the sensitivity of STANDARD M10 was 95%, the specificity was 100%, the positive predictive value was 100%, the negative predictive value was 90% and the kappa coefficient of agreement was 0.927 (p < 0.001).
STANDARD M10是一种基于试剂盒的新型实时逆转录聚合酶链反应即时检测平台，在检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）方面具有显著优势，包括周转时间短，且无需专业人员和专门设施。最近，本院对该检测方法进行了评估，将其作为日常使用的现有NeuMoDx检测方法的快速替代方法。为此，使用了本院收治患者的30份鼻咽样本，无论其是否临床怀疑患有2019冠状病毒病（COVID-19）。在我们的评估中，STANDARD M10的灵敏度为95%，特异性为100%，阳性预测值为100%，阴性预测值为90%，一致性kappa系数为0.927（p<0.001）。
Zotero 插件